Precision in motion: the first UK published experience with Stealth Autoguide robotic stereotactic brain biopsy.

Twenty-seven patients (19 male, 8 female; mean age 58 years, range 28-82) underwent robotic-assisted biopsy.

Glioblastoma (WHO Grade 4) accounted for 62.9% of diagnoses, followed by lymphoma (29.6%).

No patient experienced postoperative haemorrhage requiring intervention, new neurological deficit, or procedure-related mortality.